| Inflammatory bowel disease and cancer: The role of inflammation, immunosuppression, and cancer treatment JE Axelrad, S Lichtiger, V Yajnik World journal of gastroenterology 22 (20), 4794, 2016 | 480 | 2016 |
| Covid-19 in immune-mediated inflammatory diseases—case series from New York R Haberman, J Axelrad, A Chen, R Castillo, D Yan, P Izmirly, A Neimann, ... New England Journal of Medicine 383 (1), 85-88, 2020 | 456 | 2020 |
| Reduced Purkinje cell number in essential tremor: a postmortem study JE Axelrad, ED Louis, LS Honig, I Flores, GW Ross, R Pahwa, KE Lyons, ... Archives of neurology 65 (1), 101-107, 2008 | 256 | 2008 |
| Risk of new or recurrent cancer in patients with inflammatory bowel disease and previous cancer exposed to immunosuppressive and anti-tumor necrosis factor agents J Axelrad, O Bernheim, JF Colombel, S Malerba, A Ananthakrishnan, ... Clinical gastroenterology and hepatology 14 (1), 58-64, 2016 | 104 | 2016 |
| Gut microbiome dysbiosis in antibiotic-treated COVID-19 patients is associated with microbial translocation and bacteremia L Bernard-Raichon, M Venzon, J Klein, JE Axelrad, C Zhang, AP Sullivan, ... Nature communications 13 (1), 5926, 2022 | 90 | 2022 |
| Impact of gastrointestinal panel implementation on health care utilization and outcomes JE Axelrad, DE Freedberg, S Whittier, W Greendyke, B Lebwohl, ... Journal of clinical microbiology 57 (3), 10.1128/jcm. 01775-18, 2019 | 88 | 2019 |
| Enteric infections are common in patients with flares of inflammatory bowel disease JE Axelrad, A Joelson, PHR Green, G Lawlor, S Lichtiger, K Cadwell, ... Official journal of the American College of Gastroenterology| ACG 113 (10 …, 2018 | 88 | 2018 |
| Gastrointestinal infection increases odds of inflammatory bowel disease in a nationwide case–control study JE Axelrad, O Olén, J Askling, B Lebwohl, H Khalili, MC Sachs, ... Clinical Gastroenterology and Hepatology 17 (7), 1311-1322. e7, 2019 | 82 | 2019 |
| No association between pseudopolyps and colorectal neoplasia in patients with inflammatory bowel diseases R Mahmoud, SC Shah, JR Ten Hove, J Torres, E Mooiweer, D Castaneda, ... Gastroenterology 156 (5), 1333-1344. e3, 2019 | 80 | 2019 |
| Early life exposures and the risk of inflammatory bowel disease: systematic review and meta-analyses M Agrawal, J Sabino, C Frias-Gomes, CM Hillenbrand, C Soudant, ... EClinicalMedicine 36, 2021 | 69 | 2021 |
| ECCO guidelines on inflammatory bowel disease and malignancies H Gordon, L Biancone, G Fiorino, KH Katsanos, U Kopylov, E Al Sulais, ... Journal of Crohn's and Colitis 17 (6), 827-854, 2023 | 67 | 2023 |
| Thiopurines and inflammatory bowel disease: current evidence and a historical perspective JE Axelrad, A Roy, G Lawlor, B Korelitz, S Lichtiger World journal of gastroenterology 22 (46), 10103, 2016 | 64 | 2016 |
| Effects of cancer treatment on inflammatory bowel disease remission and reactivation JE Axelrad, SA Fowler, S Friedman, AN Ananthakrishnan, V Yajnik Clinical Gastroenterology and Hepatology 10 (9), 1021-1027. e1, 2012 | 54 | 2012 |
| The role of gastrointestinal pathogens in inflammatory bowel disease: a systematic review JE Axelrad, KH Cadwell, JF Colombel, SC Shah Therapeutic advances in gastroenterology 14, 17562848211004493, 2021 | 52 | 2021 |
| The role of the radiologist in determining disease severity in inflammatory bowel diseases P Deepak, JE Axelrad, AN Ananthakrishnan Gastrointestinal Endoscopy Clinics 29 (3), 447-470, 2019 | 51 | 2019 |
| Enteric infection in relapse of inflammatory bowel disease: the utility of stool microbial PCR testing JE Axelrad, A Joelson, YR Nobel, G Lawlor, PHR Green, S Lichtiger, ... Inflammatory Bowel Diseases 23 (6), 1034-1039, 2017 | 48 | 2017 |
| Inflammatory bowel disease and risk of small bowel cancer: a binational population-based cohort study from Denmark and Sweden JE Axelrad, O Olen, MC Sachs, R Erichsen, L Pedersen, J Halfvarson, ... Gut 70 (2), 297-308, 2021 | 47 | 2021 |
| An intestinal organoid–based platform that recreates susceptibility to T-cell–mediated tissue injury YU Matsuzawa-Ishimoto, A Hine, Y Shono, E Rudensky, A Lazrak, ... Blood, The Journal of the American Society of Hematology 135 (26), 2388-2401, 2020 | 47 | 2020 |
| Gut microbiome dysbiosis during COVID-19 is associated with increased risk for bacteremia and microbial translocation M Venzon, L Bernard-Raichon, J Klein, JE Axelrad, C Zhang, GA Hussey, ... Biorxiv, 2021 | 45 | 2021 |
| Systematic review: gastrointestinal infection and incident inflammatory bowel disease JE Axelrad, KH Cadwell, JF Colombel, SC Shah Alimentary pharmacology & therapeutics 51 (12), 1222-1232, 2020 | 44 | 2020 |
